Fig. 1From: Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CTRisk of progression (A) and death (B) stratified by SUVMax > 10 for patients with PR/SD at one month post-CAR-T. Patients with SUVMax > 10 at one-month post-CAR-T infusion had higher risk of death and progression than patients with SUVMax < 10, as demonstrated by the Kaplan–Meier curves aboveBack to article page